# DESCRIPTION

## FIELD OF THE INVENTION

- introduce human antibodies for influenza M2e antigen

## RELATED ART

- discuss limitations of current influenza A vaccines and treatments

## SUMMARY OF THE INVENTION

- identify and isolate human scFv with high affinity to M2e antigen
- generate fully human monoclonal IgG1 antibodies from scFv clones
- characterize antibodies with high affinity and specificity to M2e antigen
- demonstrate therapeutic activity in mouse model for influenza A virus infection

## DETAILED DESCRIPTION OF THE INVENTION

- define antibody
- define recognizing
- define Fv
- define single chain antibody
- define diabody
- define human antibody
- define monoclonal antibody and constant region
- define lambda LCVRs
- define HCVRs
- define CDR
- define antigen
- define extracellular domain of influenza A virus M2 protein
- define influenza M2e antigen
- define specifically binding
- define effective amount and tag
- introduce prior art
- describe monoclonal antibody
- specify CDRs of monoclonal antibody
- describe relationships between CDRs
- provide specific embodiments of monoclonal antibody
- describe modifications to obtain fully human antibodies
- define antibody structure
- specify HCVR and LCVR sequences
- describe preferred embodiments
- detail antigen binding site composition
- define monoclonal antibody
- specify LCVR and HCVR sequences
- describe recombinant antibody formats
- specify IgG1 and kappa LC sequences
- describe influenza M2e antigen binding
- specify dissociation constant ranges
- describe epitope recognition
- specify CDR sequences
- describe human IgG1 and kappa LC sequences
- summarize epitope mapping results
- describe monoclonal antibody embodiments
- describe LCVR and HCVR of monoclonal antibody
- describe nucleic acid molecules encoding HCVR or LCVR
- describe expression vectors for recombinant expression
- describe host cells comprising nucleic acid molecules or expression vectors
- describe monoclonal antibody for use as pharmaceutical
- describe pharmaceutical compositions comprising monoclonal antibody
- describe methods of passive immunization and treatment/prophylaxis of influenza A virus infection
- describe use of monoclonal antibody in detection of influenza A virus M2 protein

### EXAMPLE 1

- identify M2-specific single-chain antibodies

### EXAMPLE 2

- rescue, screen, and sequence M2-specific antibodies

### EXAMPLE 3

- express and purify M2-specific scFv-msFcγ2c fusion proteins

### EXAMPLE 4

- analyze binding of scFv-msFcγ2c fusion proteins to M2-derived peptides

### EXAMPLE 5

- analyze binding of M2-specific scFv-msFcγ2c fusion proteins to M2-expressing cells

### EXAMPLE 6

- test protective effect of M2-specific scFv-msFcγ2c fusion proteins in a mouse model

### EXAMPLE 7

- test therapeutic activity of M2-specific scFv-msFcγ2c fusion protein in a mouse model

### EXAMPLE 8

- construct, express, and purify fully human M2-specific IgG1

### EXAMPLE 9

- introduce binding of IgG1-D005 to M2-expressing 293T cells
- describe transfection of 293T cells with M2 protein variants
- detail incubation and detection of bound antibodies
- report EC50 of IgG1-D005 binding to M2-PR and M2-VN/PR
- summarize results of binding assay

